Inclusion Criteria

DISEASE CHARACTERISTICS: Histologically proven non-Hodgkin's lymphoma or Hodgkin's disease
Diffuse small cell (i.e., chronic lymphocytic leukemia, small lymphocytic, immunocytoma)
Follicular Mantle cell Peripheral T cell Diffuse large B cell Leukemic (i.e.,
lymphoblastic, Burkitt's) First relapse or first progression after responding to a salvage
regimen and high dose chemotherapy with autologous stem cell transplantation (second
remission) Response of greater than 50% of tumor mass decrease observed at time of
progression Prior high dose chemotherapy plus autologous stem cell transplantation as
first line therapy allowed

PATIENT CHARACTERISTICS: Age: 18 to 64 Performance status: ECOG 0-2 Life expectancy: Not
specified Hematopoietic: Not specified Hepatic: Bilirubin no greater than 1.5 mg/dL
Transaminase no greater than 3.0 times upper limit of normal Renal: Creatinine no greater
than 1.7 mg/dL Other: Not pregnant or nursing Fertile patients must use effective
contraception No other prior or concurrent malignancies except curatively treated (by
radiotherapy or surgery) basal cell skin cancer or carcinoma in situ

PRIOR CONCURRENT THERAPY: Biologic therapy: See Disease Characteristics No other
concurrent immunotherapy No concurrent hematopoietic growth factors Chemotherapy: See
Disease Characteristics No concurrent chemotherapy Endocrine therapy: Not specified
Radiotherapy: No concurrent radiotherapy Surgery: Not specified